The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 22, 2025
Filed:
Sep. 03, 2024
Eli Lilly and Company, Indianapolis, IN (US);
Chugai Seiyaku Kabushiki Kaisha, Shizuoka, JP;
Ayman D. Allian, Carmel, IN (US);
Kenneth Derek Berglund, Fishers, IN (US);
Kevin Paul Cole, Indianapolis, IN (US);
Ashlee Jeanette Davis, Indianapolis, IN (US);
Molly Hess, Avon, IN (US);
Adriana Jemison, Indianapolis, IN (US);
Mark Steven Kerr, Indianapolis, IN (US);
Audrey Grace Mack, Indianapolis, IN (US);
Xavier A. Ortiz-Medina, Noblesville, IN (US);
David Michael Remick, Fishers, IN (US);
Derek Robert Starkey, Avon, IN (US);
Radhe Krishan Vaid, Carmel, IN (US);
Qiang Yang, Zionsville, IN (US);
Fumiki Kawagishi, Kanagawa, JP;
Takashi Emura, Kanagawa, JP;
Satoshi Tsuchiya, Kanagawa, JP;
Manabu Wadamoto, Kanagawa, JP;
Minoru Yamawaki, Kanagawa, JP;
ELI LILLY AND COMPANY, Indianapolis, IN (US);
CHUGAI SEIYAKU KABUSHIKI KAISHA, Tokyo, JP;
Abstract
The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl ]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.